Literature DB >> 7492074

Antifungal agents in neonatal systemic candidiasis.

J N van den Anker1, N M van Popele, P J Sauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7492074      PMCID： PMC162751          DOI： 10.1128/AAC.39.7.1391

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  63 in total

1.  Treatment of neonatal Candida albicans septicemia with itraconazole.

Authors:  J N van den Anker
Journal:  Pediatr Infect Dis J       Date:  1992-08       Impact factor: 2.129

2.  Acute renal failure in a neonate due to pelviureteric candidal bezoars successfully treated with long-term systemic fluconazole.

Authors:  K A Bergman; J F Meis; A M Horrevorts; L Monnens
Journal:  Acta Paediatr       Date:  1992-09       Impact factor: 2.299

3.  Use of fluconazole in the treatment of Candida albicans hydrocephalus shunt infection.

Authors:  M Cruciani; G Di Perri; M Molesini; S Vento; E Concia; D Bassetti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

Review 4.  Candida endocarditis: successful medical management in three preterm infants and review of the literature.

Authors:  P J Sánchez; J D Siegel; J Fishbein
Journal:  Pediatr Infect Dis J       Date:  1991-03       Impact factor: 2.129

5.  Effect of cyclodextrin on the pharmacology of antifungal oral azoles.

Authors:  J S Hostetler; L H Hanson; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

6.  Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience.

Authors:  E Leibovitz; A Iuster-Reicher; M Amitai; B Mogilner
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

7.  Fluconazole in the treatment of candidiasis in immunocompromised children.

Authors:  C Viscoli; E Castagnola; F Fioredda; B Ciravegna; G Barigione; A Terragna
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

8.  Successful medical treatment of presumed Candida endocarditis in critically ill infants.

Authors:  P N Zenker; E M Rosenberg; R B Van Dyke; G P Rabalais; R S Daum
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

9.  Candida albicans septicemia in a premature infant successfully treated with oral fluconazole.

Authors:  S Bodé; L Pedersen-Bjergaard; K Hjelt
Journal:  Scand J Infect Dis       Date:  1992

10.  Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group.

Authors:  P Sandven; A Bjørneklett; A Maeland
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191
View more
  8 in total

1.  Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility.

Authors:  J L Rowen; J M Tate; N Nordoff; L Passarell; M R McGinnis
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

Review 2.  Neonatal sepsis: epidemiology and management.

Authors:  Robert S Baltimore
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 3.  Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review.

Authors:  J Evdoridou; E Roilides; E Bibashi; G Kremenopoulos
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

4.  Survey of neonatal candidiasis in Greece.

Authors:  J Dotis; J Evdoridou; G Kremenopoulos; E Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

Review 5.  Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Authors:  Chris Stockmann; Michael G Spigarelli; Sarah C Campbell; Jonathan E Constance; Joshua D Courter; Emily A Thorell; Jared Olson; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

Review 6.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates.

Authors:  A Juster-Reicher; O Flidel-Rimon; M Amitay; S Even-Tov; E Shinwell; E Leibovitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-12       Impact factor: 3.267

8.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.